L&C Bio Co., Ltd

KOSDAQ 290650.KQ

L&C Bio Co., Ltd Total Assets for the year ending December 31, 2023: USD 201.39 M

L&C Bio Co., Ltd Total Assets is USD 201.39 M for the year ending December 31, 2023, a 27.64% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

L&C Bio Co., Ltd Total Assets for the year ending December 31, 2022 was USD 157.78 M, a 75.52% change year over year.
L&C Bio Co., Ltd Total Assets for the year ending December 31, 2021 was USD 89.89 M, a 21.53% change year over year.
L&C Bio Co., Ltd Total Assets for the year ending December 31, 2020 was USD 73.97 M, a 29.57% change year over year.
L&C Bio Co., Ltd Total Assets for the year ending December 31, 2019 was USD 57.09 M, a 11.29% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

KOSDAQ: 290650.KQ

L&C Bio Co., Ltd

CEO	Mr. Chul Lee Whan
IPO Date	Nov. 1, 2018
Location	South Korea
Headquarters	Suntechcity
Employees	122
Sector	Health Care
Industries Biotechnology Cosmetics Pharmaceuticals Research & Consulting

Description

L&C BIO Co., Ltd. operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam, South Korea.

Key trends

Past 5 years